With 0.54 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.24 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $5.8299 whereas the lowest price it dropped to was $5.055. The 52-week range on AVR shows that it touched its highest point at $8.79 and its lowest point at $2.34 during that stretch. It currently has a 1-year price target of $14.67. Beta for the stock currently stands at 1.08.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AVR was up-trending over the past week, with a rise of 4.19%, but this was up by 55.84% over a month. Three-month performance surged to 4.39% while six-month performance rose 34.40%. The stock lost -1.97% in the past year, while it has lost -0.55% so far this year. A look at the trailing 12-month EPS for AVR yields -2.34 with Next year EPS estimates of -1.78. For the next quarter, that number is -0.56. This implies an EPS growth rate of 35.87% for this year and 24.36% for next year.
Float and Shares Shorts:
At present, 41.20 million AVR shares are outstanding with a float of 41.12 million shares on hand for trading. On 2025-11-28, short shares totaled 1.53 million, which was 371.00002 higher than short shares on 1761868800. In addition to Mr. Wayne Geoffrey Paterson as the firm’s Vice Chairman & CEO, Mr. David St. Denis serves as its President & Director.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-09-30, AVR reported revenue of $nan and operating income of $nan. The EBITDA in the recently reported quarter was $nan and diluted EPS was -$0.62.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With AVR analysts setting a high price target of 22.0 and a low target of 9.0, the average target price over the next 12 months is 16.5. Based on these targets, AVR could surge 302.19% to reach the target high and rise by 64.53% to reach the target low. Reaching the average price target will result in a growth of 201.65% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$2.34992 being high and -$3.58614 being low. For AVR, this leads to a yearly average estimate of -$2.9736.
